Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
GSK Supply Status
At this time, COVID-19 is not having an impact on GSK supply in the UK.
Please note: this page is updated weekly. If a product is not listed below, GSK are not experiencing supply constraints. Please contact your wholesaler
Product name |
PIP Code |
Status |
Estimated recovery date |
|---|---|---|---|
| BACTROBAN NASAL OINT 2% TUBE 3GX1 UK-GSK | 171991 | OUT OF STOCK | EARLY DECEMBER 2022 |
| BETNOVATE CRM 0.1% 30G UK-GSK | 29447 | OUT OF STOCK | EARLY DECEMBER 2022 |
| BETNOVATE RD OINT 0.025% 100G UK-GSK | 485227 | OUT OF STOCK | EARLY DECEMBER 2022 |
| DARAPRIM TAB 25MG BLISTER 30S - UK | 68999 | OUT OF STOCK | LATE FEBRUARY 2023 |
| DUAC GEL 10MG/G + 50MG/G 1X60G_UK-STF | 3952603 | OUT OF STOCK | MID NOVEMBER 2022 |
| EUMOVATE CRM 0.05% 100G UK-GSK | 483503 | OUT OF STOCK | LATE DECEMBER 2022 |
| EUMOVATE CRM 0.05% 30G UK-GSK | 143198 | OUT OF STOCK | MID DECEMBER 2022 |
| EUMOVATE OINT 0.05% 30G UK-GSK | 143214 | OUT OF STOCK | MID NOVEMBER 2022 |
| VENTOLIN RESP SOLN 20ML UK-AH | 3445525 | OUT OF STOCK | EARLY DECEMBER 2022 |
| VOLUMATIC INHALATION DEVICE | 162792 | OUT OF STOCK | EARLY JANUARY 2023 |
| VOLUMATIC PAED 1X1 | 978981 | OUT OF STOCK | EARLY JANUARY 2023 |
| ZYBAN TAB 150MG 6X10_GB | 2709848 | OUT OF STOCK | TBC |
If you have any queries about the availability of a product, please contact your wholesaler.
Further information
If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com).
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
